We took the three targets with highest predicted probability; ERBB4 (0.790), EGFR (0.784) and ERBB2/HER2 (0.724) all known to be expressed in HER2 + breast cancer [44, 45], to the causal reasoning analysis stage. This evidence concerns the gene EGFR and breast carcinoma.